CARBYLAN THERAPEUTICS INC's ticker is CBYL and the CUSIP is 141384107. A total of 32 filers reported holding CARBYLAN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,178,941 | $8,429,000 | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $2,860,000 | 0.28% |
| PURA VIDA INVESTMENTS, LLC | 40,000 | $276,000 | 0.14% |
| Omega Advisors Inc. | 100,000 | $715,000 | 0.01% |
| PUTNAM INVESTMENTS LLC | 634,780 | $4,539,000 | 0.01% |
| Pentwater Capital Management LP | 225,000 | $1,609,000 | 0.01% |
| Alyeska Investment Group, L.P. | 199,736 | $1,428,000 | 0.01% |
| PANAGORA ASSET MANAGEMENT INC | 207,158 | $1,481,000 | 0.01% |
| FRANKLIN RESOURCES INC | 1,524,100 | $10,897,000 | 0.01% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,803,300 | $20,044,000 | 0.00% |